US 7163678
Reovirus for the treatment of ral-mediated cellular proliferative disorders
granted A61KA61K35/765
Quick answer
US patent 7163678 (Reovirus for the treatment of ral-mediated cellular proliferative disorders) held by ONCOLYTICS BIOTECH INC. expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ONCOLYTICS BIOTECH INC.
- Grant date
- Tue Jan 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61K, A61K35/765